Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit

Oncology

Volumn 70, Issue 3, 2006, Pages 173-176

  Avilés, Agustin ^a   Neri, Natividad ^a   Calva, Angel ^a   Huerta Guzmán, Judith ^a   Cleto, Sergio ^a   Nambo, M Jésus ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Combined therapy; Malignant lymphoma; Orbital malignant lymphoma; Radiotherapy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; INFECTION; KERATITIS; MAJOR CLINICAL STUDY; MALE; ORBIT CANCER; PRIMARY ORBIT MALIGNANT LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RARE DISEASE; SHORT COURSE THERAPY; SJOEGREN SYNDROME; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; ORBITAL NEOPLASMS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33746656637     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093804     Document Type: Article

References (18)

1. Tewtik HH, Platz CE, Corder MA: A clinicopathological study of orbital and adnexal non-Hodgkin's lymphoma. Cancer 1979;44:1022-1028.
2. Knowles DM, Jakobiec FA: Orbital lymphoid neoplasm: a clinicopathologic study of 60 patients. Cancer 1980;46:576-589.
3. Knowles DM, Jakobiec FA, McNally L, Burke JS: Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Human Pathol 1990;21:959-973.
4. Shetar DJ: Management of orbital lymphoid lesions. Opthalmol Clin North Am 2000;13:508-515.
5. Cahill M, Burres C, Moriarty P, et al: Ocular adnexal lymphoma. Comparison of MALT lymphoma with other histological types. Br J Ophtalmol 1999;83:742-751.
6. Zinzani PL, Magagnoli M, Gallieri P, et al: Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254-1258.
7. White WL, Ferry JA, Harris NL, Groves AS Jr: Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995;102:1994-2006.
8. Reddy S, Sayers US, Pelletiere U, Hendrickson FR: Early nodal and extranodal non-Hodgkin's lymphoma. Cancer 1977;40:98-104.
9. Margolis L, Fraser R, Lichter A, Char DH: The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980;45:688-692.
10. Minehan KJ, Martenson JA, Garrity JA: Local control and complications after radiation therapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 1991;20:791-796.
11. Letscher VGJ, Gonzalez GD, Oskam J: Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma. Radiother Oncol 1991;22:36-44.
12. Smitt MC, Donaldson SS: Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys 1993;26:59-66.
13. Bolek T, Moyses HM, Marcus RB: Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44:31-36.
14. Bairey O, Kremer I, Rakowsky E, et al: Orbital and adnexal involvement in systemic non-Hodgkin's lymphoma. Cancer 1994;73:2395-2399.
15. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.
16. Kaplan EL, Meier P: Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-481.
17. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918.
18. Avilés A, Delgado S, Fernández R, Talavera A, Neri N, Huerta-Guzmán J: Combined therapy in advanced (stages III and IV) follicular lymphoma increases the possibility of cure. Eur J Hematol 2002;68:144-149.